TGFBR2 and neoplasm: As a result, it leads to epigenetic silencing of gene expressions and subsequently, the inactivation of the relevant gene (i.e., MLH1) followed by mutation of tumor suppression genes encoding tumor-suppression proteins (i.e., TGFBR2 and BAX) [6].